18 February 2011 Steroid-induced osteoporosis monitored by Raman spectroscopy
Author Affiliations +
Abstract
Glucocorticoids are frequently used to treat inflammatory disorders such as rheumatoid arthritis. Unfortunately, extended exposure to this steroid is the leading cause of physician-induced osteoporosis, leaving patients susceptible to fractures at rates of 30-50%. In this presentation, we report correlations between Raman spectra and biomechanical strength tests on bones of glucocorticoid- and placebo- treated mice. Both wild-type mice and a transgenic model of rheumatoid arthritis have been studied. A two-way ANOVA model reveals statistically significant spectral differences as influenced by glucocorticoid treatment and mouse type.
© (2011) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jason R. Maher, Jason R. Maher, Masahiko Takahata, Masahiko Takahata, Hani A. Awad, Hani A. Awad, Andrew J. Berger, Andrew J. Berger, } "Steroid-induced osteoporosis monitored by Raman spectroscopy", Proc. SPIE 7883, Photonic Therapeutics and Diagnostics VII, 78834H (18 February 2011); doi: 10.1117/12.873953; https://doi.org/10.1117/12.873953
PROCEEDINGS
7 PAGES


SHARE
Back to Top